Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality.
about
Low-dose rate brachytherapy for men with localized prostate cancerComparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study GroupRe-implantation of suboptimal prostate seed implantation: technique with intraoperative treatment planning.Intraoperative 3D reconstruction of prostate brachytherapy implants with automatic pose correctionIs it necessary to perform week three dosimetric analysis in low-dose-rate brachytherapy for prostate cancer when day 0 dosimetry is done? A quality assurance assessment.Iodine seed prostate brachytherapy: an alternative first-line choice for early prostate cancer.Comparison of permanent (125)I seeds implants with two different techniques in 500 cases of prostate cancer.Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98.Analysis of monotherapy prostate brachytherapy in patients with prostate cancer. Initial PSA and Gleason are important for recurrence?The radioactive autopsy: safe working practices.The impact of body mass index on dosimetric quality in low-dose-rate prostate brachytherapy.Preoperative treatment planning with intraoperative optimization can achieve consistent high-quality implants in prostate brachytherapy.Long-term tumor control after brachytherapy for base-of-prostate cancerAmerican Brachytherapy Society Task Group Report: Use of androgen deprivation therapy with prostate brachytherapy-A systematic literature review.Current status of brachytherapy for prostate cancer.Comparative effectiveness of cryotherapy vs brachytherapy for localised prostate cancer.Evaluation of dosimetry and excess seeds in permanent brachytherapy using a modified hybrid method: a single-institution experience.Evaluation of intraoperative magnetic resonance imaging/ultrasound fusion optimization for low-dose-rate prostate brachytherapy.Pre-plan parameters predict post-implant D90 ≥ 140 Gy for (125)I permanent prostate implants.Case series analysis of post-brachytherapy prostate edema and its relevance to post-implant dosimetry. Post-implant prostate edema and dosimetry.Dosimetry advantages of intraoperatively built custom-linked seeds compared with loose seeds in permanent prostate brachytherapy.Detection of prostate specific transcripts in the peripheral blood during brachytherapy predicts postoperative PSA kinetics.Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.Image guided I125 prostate brachytherapy with Hybrid Interactive Mick technique in the community setting: How does it compare?Salvage robotic-assisted radical prostatectomy: initial results and early report of outcomes.A UK-based investigation of inter- and intra-observer reproducibility of Gleason grading of prostatic biopsies.Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
P2860
Q24235544-00F809D1-A47F-4F2D-919F-83846EDBDC52Q27011661-CE459B32-41DF-4C40-AA7B-BABD847AE949Q30422778-D13C577E-AF07-4468-890C-CCB43F4A8FCBQ30464864-37412272-EF01-41FE-B3A6-95518D8DE0EFQ35582296-1E3FD147-F189-4DDF-A873-0EFCF0B29F9AQ35797101-561FCE25-4FA2-4082-9685-6DFA33024DFBQ36276830-327CCAF6-4D5E-443E-B500-B00533BFABCEQ36332043-0D902F15-DB84-40BA-9444-8058D520066FQ36575837-09788C0C-1418-4A29-971E-076DC00CFB44Q36889322-5CF980DE-72F2-4A65-8111-DC7BE6512FAAQ37424415-3737BE50-C35A-4894-BA27-66AE33CA6C0DQ37604554-319E2A5A-4530-4E92-A4D8-87EBC7F71741Q38076418-17E70FAF-49E9-4929-A5F8-F85532E2B7FDQ39006967-BB2C8BE8-56BE-416F-BC35-7FD1266E16E2Q39513542-980F3773-CDFD-43C1-B409-FEA940745755Q40013234-9C482B26-C85C-4451-93CF-33CA059515DBQ40611135-FF723214-9D5C-4374-978C-99F53A774A66Q41689143-59E4F824-3A9B-4132-A85A-4F0222837C1BQ41829621-9E3741DD-727E-4C85-9C9E-C9517B7D254EQ42174967-D5D12287-C009-40EA-BDFF-4BFB7F45FE29Q47134635-D060BF67-16E5-4957-A018-B630408C407AQ47822522-9071E19A-3FE7-459D-B3DF-95D98A74A0E9Q50948637-A0EA7DF1-EB4D-4C68-A6ED-D157E200297FQ51426653-33B8B84B-164F-4BD6-A602-5AF449FEE3B2Q51694893-4604CA57-ED96-4CE0-97B8-F8617527D559Q51860274-9990F21A-33D3-41FB-B187-A2F5BA9F915BQ53003551-D2CD7328-791F-4E26-9E62-07C4C2C89F74Q53223314-9F72762B-C24C-48D1-BAF8-C1DAA640B7EA
P2860
Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Biochemical outcomes after pro ...... selection and implant quality.
@en
Biochemical outcomes after pro ...... selection and implant quality.
@nl
type
label
Biochemical outcomes after pro ...... selection and implant quality.
@en
Biochemical outcomes after pro ...... selection and implant quality.
@nl
prefLabel
Biochemical outcomes after pro ...... selection and implant quality.
@en
Biochemical outcomes after pro ...... selection and implant quality.
@nl
P2093
P1476
Biochemical outcomes after pro ...... selection and implant quality.
@en
P2093
Marisa A Kollmeier
Nelson Stone
Richard G Stock
P304
P356
10.1016/S0360-3016(03)00627-8
P407
P577
2003-11-01T00:00:00Z